Joanna Shisler

Dr. Joanna Shisler


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
FCFrancis Ka-Ming Chan
Francis Ka-Ming Chan
JSJoanna Shisler
Joanna Shisler
JBJacqueline G. Bixby
Jacqueline G. Bixby
MFMartin Felices
Martin Felices
LZLixin Zheng
Lixin Zheng
MLMichael J. Lenardo
Michael J. Lenardo
Members of the tumor necrosis factor (TNF) receptor (TNFR) superfamily are potent regulators of apoptosis, a process that is important for the maintenance of immune homeostasis. Recent evidence suggests that TNFR-1 and Fas and TRAIL receptors can also trigger an alternative form of cell death that is morphologically distinct from apoptosis. Because distinct molecular components including the serine/threonine protein kinase receptor-interacting protein (RIP) are required, we have referred to this alternative form of cell death as "programmed necrosis." We show that TNFR-2 signaling can potentiate programmed necrosis via TNFR-1. When cells were pre-stimulated through TNFR-2 prior to subsequent activation of TNFR-1, enhanced cell death and recruitment of RIP to the TNFR-1 complex were observed. However, TNF-induced programmed necrosis was normally inhibited by caspase-8 cleavage of RIP. To ascertain the physiological significance of RIP and programmed necrosis, we infected Jurkat cells with vaccinia virus (VV) and found that VV-infected cells underwent programmed necrosis in response to TNF, but deficiency of RIP rescued the infected cells from TNF-induced cytotoxicity. Moreover, TNFR-2-/- mice exhibited reduced inflammation in the liver and defective viral clearance during VV infection. Interestingly, death effector domain-containing proteins such as MC159, E8, K13, and cellular FLIP, but not the apoptosis inhibitors Bcl-xL, p35, and XIAP, potently suppressed programmed necrosis. Thus, TNF-induced programmed necrosis is facilitated by TNFR-2 signaling and caspase inhibition and may play a role in controlling viral infection.

13 November 2015 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
PDF file
ETE. S. M. Tuppurainen
E. S. M. Tuppurainen
EVE. H. Venter
E. H. Venter
JSJ. L. Shisler
J. L. Shisler
GGG. Gari
G. Gari
GMG. A. Mekonnen
G. A. Mekonnen
LBL. A. Babiuk
L. A. Babiuk
Lumpy skin disease, sheeppox and goatpox are high-impact diseases of domestic ruminants with a devastating effect on cattle, sheep and goat farming industries in endemic regions. In this article, we review the current geographical distribution, economic impact of an outbreak, epidemiology, transmission and immunity of capripoxvirus. The special focus of the article is to scrutinize the use of currently available vaccines to investigate the resource needs and challenges that will have to be overcome to improve disease control and eradication, and progress on the development of safer and more effective vaccines. In addition, field evaluation of the efficacy of the vaccines and the genomic database available for poxviruses are discussed.

25 June 2015 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AGAimee M. Gall
Aimee M. Gall
BMBenito J. Mariñas
Benito J. Mariñas
YLYi Lu
Yi Lu
JSJoanna L. Shisler
Joanna L. Shisler

1 April 2004 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
JSJoanna L. Shisler
Joanna L. Shisler
XJXiao-Lu Jin
Xiao-Lu Jin
Vaccinia virus wild-type strains such as Ankara and WR synthesize proteins capable of inhibiting the activation of host NF-κB, a family of transcription factors that regulate the expression of inflammatory genes. In contrast, an infection by the attenuated MVA strain, whose genome lacks many immunoregulatory genes present in the DNA of its Ankara parent, induces NF-κB activation. Insertion of NF-κB inhibitory genes into the MVA DNA, then, would alter the MVA phenotype. By this method, a 5.2-kb region of Ankara DNA containing the K1L gene and two other genes that are absent in the MVA genome that was identified as NF-κB was inhibited in cells infected with the MVA/5.2kb virus. To determine if K1L was responsible, the relevant biological properties of both a recombinant MVA containing a copy of the WR strain's K1L (MVA/K1L) and a WR deletion mutant lacking the K1L gene (ΔK1L) were examined. Indeed, unlike its progenitor, the altered MVA halted degradation of the host regulatory protein IκBα—a key event in the pathway of transcriptional activation by NF-κB factors. Moreover, MVA/K1L gained the ability to repress artificially contrived and natural NF-κB-regulated expression of a transfected luciferase and the cellular tumor necrosis factor gene, respectively. In contrast, although these functions could also be performed by WR, the ΔK1L virus lost these abilities. Thus, one apparent molecular function of K1L is to prevent IκBα degradation. This impediment to NF-κB-induced host proinflammatory gene expression, in turn, might enhance virus survival.

2 January 1998 in Science
Verified
Journal Article
Closed access
PDF file
JSJoanna L. Shisler
Joanna L. Shisler
TSTatiana G. Senkevich
Tatiana G. Senkevich
MBMarla J. Berry
Marla J. Berry
BMBernard Moss
Bernard Moss
Selenium, an essential trace element, is a component of prokaryotic and eukaryotic antioxidant proteins. A candidate selenoprotein homologous to glutathione peroxidase was deduced from the sequence of molluscum contagiosum, a poxvirus that causes persistent skin neoplasms in children and acquired immunodeficiency syndrome (AIDS) patients. Selenium was incorporated into this protein during biosynthesis, and a characteristic stem-loop structure near the end of the messenger RNA was required for alternative selenocysteine decoding of a potential UGA stop codon within the open reading frame. The selenoprotein protected human keratinocytes against cytotoxic effects of ultraviolet irradiation and hydrogen peroxide, providing a mechanism for a virus to defend itself against environmental stress.

1 February 2001 in Seminars in Immunology
Verified
Journal Article
Closed access
BMBernard Moss
Bernard Moss
JSJoanna L. Shisler
Joanna L. Shisler